tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RPTX Stock Latest News

Repare Sells Key Oncology Asset to Gilead, Lifts Expected Xeno Deal Payout
Company AnnouncementsRepare Sells Key Oncology Asset to Gilead, Lifts Expected Xeno Deal Payout
8h ago
RPTX
Repare Therapeutics announces Gilead to acquire RP-3467 for up to $30M
PremiumThe Fly
Repare Therapeutics announces Gilead to acquire RP-3467 for up to $30M
3d ago
GILD
RPTX
Repare Therapeutics announces CSO resignation and transition plan
PremiumCompany Announcements
Repare Therapeutics announces CSO resignation and transition plan
7d ago
8K
RPTX
Repare Therapeutics Announces Shareholder Meeting for Acquisition Approval
PremiumCompany Announcements
Repare Therapeutics Announces Shareholder Meeting for Acquisition Approval
11d ago
RPTX
Repare Therapeutics Reports Positive Q3 2025 Results
PremiumCompany Announcements
Repare Therapeutics Reports Positive Q3 2025 Results
1M ago
RPTX
Repare Therapeutics Announces Acquisition by XenoTherapeutics
PremiumCompany AnnouncementsRepare Therapeutics Announces Acquisition by XenoTherapeutics
1M ago
8K
RPTX
Repare Therapeutics downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Repare Therapeutics downgraded to Hold from Buy at TD Cowen
1M ago
RPTX
Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move
Premium
Company Announcements
Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move
1M ago
RPTX
Repare Therapeutics trading resumes
PremiumThe Fly
Repare Therapeutics trading resumes
1M ago
RPTX
Repare Therapeutics reports Q3 EPS 8c vs. (81c) last year
PremiumThe Fly
Repare Therapeutics reports Q3 EPS 8c vs. (81c) last year
1M ago
RPTX
XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR
PremiumThe Fly
XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR
1M ago
RPTX
XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR
PremiumThe Fly
XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR
1M ago
RPTX
Repare Therapeutics trading halted, news pending
PremiumThe FlyRepare Therapeutics trading halted, news pending
1M ago
RPTX
Repare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look
Premium
Company Announcements
Repare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look
2M ago
RPTX
Repare Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
Premium
The Fly
Repare Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
2M ago
RPTX
Repare Therapeutics Unveils Phase 1 LIONS Trial Data
PremiumCompany Announcements
Repare Therapeutics Unveils Phase 1 LIONS Trial Data
2M ago
8K
RPTX
Repare Therapeutics: Strategic Partnerships and Cautious Optimism Amid Uncertain Trial Outcomes Justify Hold Rating
PremiumRatings
Repare Therapeutics: Strategic Partnerships and Cautious Optimism Amid Uncertain Trial Outcomes Justify Hold Rating
5M ago
RPTX
Repare Therapeutics Reports Q2 2025 Results and Strategic Moves
PremiumCompany Announcements
Repare Therapeutics Reports Q2 2025 Results and Strategic Moves
5M ago
RPTX
Repare Therapeutics Announces Licensing Deal and Strategic Updates
PremiumCompany Announcements
Repare Therapeutics Announces Licensing Deal and Strategic Updates
5M ago
RPTX
Repare Therapeutics reports Q2 EPS (39c) vs. (82c) last year
PremiumThe FlyRepare Therapeutics reports Q2 EPS (39c) vs. (82c) last year
5M ago
RPTX
Repare Therapeutics Signs Licensing Deal with Debiopharm
Premium
Company Announcements
Repare Therapeutics Signs Licensing Deal with Debiopharm
5M ago
8K
RPTX
Closing Bell Movers: Victory Capital gains on S&P 400 inclusion
Premium
The Fly
Closing Bell Movers: Victory Capital gains on S&P 400 inclusion
5M ago
BHF
BLK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >